Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells Via RhoA/Rho-Kinase Signaling Pathway Inhibition

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Jul 25

PMID 26207907

Citations 11

Authors

Noemi Serra

Roser Rosales

Lluis Masana

Joan-Carles Vallve

Affiliations

Soon will be listed here.

Abstract

The composition and structure of the extracellular matrix (ECM) in the vascular wall and in the atherosclerotic plaque are important factors that determine plaque stability. Statins can stabilize atherosclerotic plaques by modulating ECM protein expression. Fibulins are important components of the ECM. We evaluated the in vitro effect of simvastatin on the expression of fibulin-1, -2, -4 and -5 in human coronary artery smooth muscle cells (SMCs) and the mechanisms involved. Cells were incubated with simvastatin (0.05-1 μM), mevalonate (100 and 200 μM), geranylgeranyl pyrophosphate (GGPP) (15 μM), farnesyl pyrophosphate (FPP) (15 μM), the Rho kinase (ROCK) inhibitor Y-27632 (15 and 20 μM), the Rac-1 inhibitor (another member of Rho family) NSC23766 (100 μM), arachidonic acid (a RhoA/ROCK activator, 25-100 μM) and other fatty acids that are not activators of RhoA/ROCK (25-100 μM). Gene expression was analyzed by quantitative real-time PCR, and fibulin protein levels were analyzed by western blotting and ELISA. Simvastatin induced a significant increase in mRNA and protein levels of fibulin-2 at 24 hours of incubation (p<0.05), but it did not affect fibulin-1, -4, and -5 expression. Mevalonate and GGPP were able to reverse simvastatin's effect, while FPP did not. In addition, Y-27632, but not NSC23766, significantly increased fibulin-2 expression. Furthermore, activation of the RhoA/ROCK pathway with arachidonic acid decreased fibulin-2 mRNA. Simvastatin increased mRNA levels and protein expression of the ECM protein fibulin-2 through a RhoA and Rho-Kinase-mediated pathway. This increase could affect the composition and structure of the ECM.

Citing Articles

Roles of Y-27632 on sheep sperm metabolism.

Fu Y, Shen W, Bai H, Zhang Z, Cao Z, Liu Z J Anim Sci. 2024; 102.

PMID: 38263469 PMC: 10889731. DOI: 10.1093/jas/skae020.

TMT-based quantitative proteomic analysis revealed that FBLN2 and NPR3 are involved in the early osteogenic differentiation of mesenchymal stem cells (MSCs).

Liu J, He S, Ma B, Li X, Wang Y, Xiong J Aging (Albany NY). 2023; 15(15):7637-7654.

PMID: 37543430 PMC: 10457061. DOI: 10.18632/aging.204931.

Simvastatin alleviates epithelial-mesenchymal transition and oxidative stress of high glucose-induced lens epithelial cells by inhibiting RhoA/ROCK signaling.

Fu J, Hu X Exp Ther Med. 2022; 23(6):420.

PMID: 35601076 PMC: 9117960. DOI: 10.3892/etm.2022.11347.

Correlation of Fibulin-2 expression with proliferation, migration and invasion of breast cancer cells.

Zhang X, Duan L, Zhang Y, Zhao H, Yang X, Zhang C Oncol Lett. 2020; 20(2):1945-1951.

PMID: 32724439 PMC: 7377204. DOI: 10.3892/ol.2020.11747.

Ghrelin suppresses migration of macrophages via inhibition of ROCK2 under chronic intermittent hypoxia.

Chen H, Du J, Zhang S, Tong H, Zhang M J Int Med Res. 2020; 48(6):300060520926065.

PMID: 32485129 PMC: 7273871. DOI: 10.1177/0300060520926065.

References

Gu Y, Nilsson K, Eng H, Ekblom M . Association of extracellular matrix proteins fibulin-1 and fibulin-2 with fibronectin in bone marrow stroma. Br J Haematol. 2000; 109(2):305-13. DOI: 10.1046/j.1365-2141.2000.02011.x. View

Ruperez M, Rodrigues-Diez R, Blanco-Colio L, Sanchez-Lopez E, Rodriguez-Vita J, Esteban V . HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways. Hypertension. 2007; 50(2):377-83. DOI: 10.1161/HYPERTENSIONAHA.107.091264. View

Fukumoto Y, Libby P, Rabkin E, Hill C, Enomoto M, Hirouchi Y . Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation. 2001; 103(7):993-9. DOI: 10.1161/01.cir.103.7.993. View

Olin A, Morgelin M, Sasaki T, Timpl R, Heinegard D, Aspberg A . The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem. 2000; 276(2):1253-61. DOI: 10.1074/jbc.M006783200. View

Herman M, Sukhova G, Libby P, Gerdes N, Tang N, Horton D . Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation. 2001; 104(16):1899-904. DOI: 10.1161/hc4101.097419. View

Libby P, Aikawa M . Mechanisms of plaque stabilization with statins. Am J Cardiol. 2003; 91(4A):4B-8B. DOI: 10.1016/s0002-9149(02)03267-8. View

Argraves W, Greene L, Cooley M, Gallagher W . Fibulins: physiological and disease perspectives. EMBO Rep. 2003; 4(12):1127-31. PMC: 1326425. DOI: 10.1038/sj.embor.7400033. View

Nissen S, Tuzcu E, Schoenhagen P, Brown B, Ganz P, Vogel R . Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004; 291(9):1071-80. DOI: 10.1001/jama.291.9.1071. View

Chu M, Tsuda T . Fibulins in development and heritable disease. Birth Defects Res C Embryo Today. 2004; 72(1):25-36. DOI: 10.1002/bdrc.20003. View

10.

Schaar J, Muller J, Falk E, Virmani R, Fuster V, Serruys P . Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J. 2004; 25(12):1077-82. DOI: 10.1016/j.ehj.2004.01.002. View

11.

Davignon J . Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004; 109(23 Suppl 1):III39-43. DOI: 10.1161/01.CIR.0000131517.20177.5a. View

12.

Stone E, Braun T, Russell S, Kuehn M, Lotery A, Moore P . Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med. 2004; 351(4):346-53. DOI: 10.1056/NEJMoa040833. View

13.

Moreno P, Purushothaman K, Fuster V, Echeverri D, Truszczynska H, Sharma S . Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation. 2004; 110(14):2032-8. DOI: 10.1161/01.CIR.0000143233.87854.23. View

14.

Shah P, Falk E, Badimon J, Fernandez-Ortiz A, Mailhac A, Fallon J . Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995; 92(6):1565-9. View

15.

Sasaki T, Gohring W, Pan T, Chu M, Timpl R . Binding of mouse and human fibulin-2 to extracellular matrix ligands. J Mol Biol. 1995; 254(5):892-9. DOI: 10.1006/jmbi.1995.0664. View

16.

Reinhardt D, Sasaki T, Dzamba B, Keene D, Chu M, Gohring W . Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. J Biol Chem. 1996; 271(32):19489-96. DOI: 10.1074/jbc.271.32.19489. View

17.

Utani A, Nomizu M, Yamada Y . Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences. J Biol Chem. 1997; 272(5):2814-20. DOI: 10.1074/jbc.272.5.2814. View

18.

Sasaki T, Wiedemann H, Matzner M, Chu M, Timpl R . Expression of fibulin-2 by fibroblasts and deposition with fibronectin into a fibrillar matrix. J Cell Sci. 1996; 109 ( Pt 12):2895-904. DOI: 10.1242/jcs.109.12.2895. View

19.

Wu X, Shang A, Jiang H, Ginsberg H . Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells. Arterioscler Thromb Vasc Biol. 1997; 17(11):3347-55. DOI: 10.1161/01.atv.17.11.3347. View

20.

Bellosta S, Via D, Canavesi M, Pfister P, Fumagalli R, Paoletti R . HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol. 1998; 18(11):1671-8. DOI: 10.1161/01.atv.18.11.1671. View